Lithium, a well-known pharmacological agent, sensitizes melanoma cells to ferroptosis by downregulating FTH, thereby increasing labile iron pools and synergizing with RSL3 to inhibit tumor growth and promote CD8+ T-cell infiltration (180). The gene discussed is CD8A; the disease is neoplasm.